Fingerpaint Group announced the acquisition of Parsons Medical Communications (PMC), a full-service scientific organization focused on the eyecare segment, adding to Fingerpaint Group’s strong medical communications offerings. Details of the transaction were not disclosed.
Fingerpaint Group partnered with the San Francisco–based private equity firm Knox Lane in December 2020 to accelerate its trajectory through organic growth and strategic partnerships. Since then, Fingerpaint Group has experienced exponential growth in its roster of both capabilities and talent.
“According to the National Eye Institute, nearly 117 million people will be affected by some type of vision-related problem by 2030,” said Bill McEllen, Global President of Fingerpaint Group. “Ensuring those people have access to the treatments they need, and healthcare practitioners have the opportunity to best deliver those treatments, will be critical to providing positive outcomes for all stakeholders.”
Parsons Medical Communications will join Fingerpaint Group’s branch of Specialty Services offerings at Fingerpaint Group. Erin Parsons, founder of Parsons Medical Communications, will continue to lead the Parsons team as Managing Director and will work with Scott Goudy, President of Fingerpaint Group’s MedThink Group.
“Adding Parsons Medical Communications to our team of experts will not only enhance our communications offering but is also a testament to Fingerpaint Group’s commitment to the eyecare segment,” said Goudy. “Erin and her team have deep industry knowledge and clinical understanding of all therapeutic areas when it comes to eyecare.”